440 related articles for article (PubMed ID: 11743354)
21. Expression of platelet-derived endothelial cell growth factor in bladder carcinoma.
Mizutani Y; Okada Y; Yoshida O
Cancer; 1997 Mar; 79(6):1190-4. PubMed ID: 9070497
[TBL] [Abstract][Full Text] [Related]
22. Specific enhanced expression of platelet-derived endothelial cell growth factor in submucosa of human colorectal cancer.
Nozawa T; Enomoto T; Koshida Y; Sato Y; Kuranami M
Dis Colon Rectum; 2004 Dec; 47(12):2093-100. PubMed ID: 15657660
[TBL] [Abstract][Full Text] [Related]
23. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
[TBL] [Abstract][Full Text] [Related]
24. Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis.
Bouchelouche K; Kristensen B; Nordling J; Horn T; Bouchelouche P
J Urol; 2001 Dec; 166(6):2121-5. PubMed ID: 11696719
[TBL] [Abstract][Full Text] [Related]
25. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis.
Liu HT; Kuo HC
Urology; 2007 Sep; 70(3):463-8. PubMed ID: 17905097
[TBL] [Abstract][Full Text] [Related]
26. Comparison of cystoscopic and histological findings in patients with suspected interstitial cystitis.
Denson MA; Griebling TL; Cohen MB; Kreder KJ
J Urol; 2000 Dec; 164(6):1908-11. PubMed ID: 11061878
[TBL] [Abstract][Full Text] [Related]
27. Expression of thymidine phosphorylase in human superficial bladder cancer.
Shimabukuro T; Matsuyama H; Baba Y; Jojima K; Suyama K; Aoki A; Suga A; Yamamoto N; Naito K
Int J Urol; 2005 Jan; 12(1):29-34. PubMed ID: 15661051
[TBL] [Abstract][Full Text] [Related]
28. Increased urinary levels of Tamm-Horsfall glycoprotein suggest a systemic etiology of interstitial cystitis.
Bade JJ; Marrink J; Karrenbeld A; van der Weele L; Mensink HJ
J Urol; 1996 Sep; 156(3):943-6. PubMed ID: 8709369
[TBL] [Abstract][Full Text] [Related]
29. Expression of transforming growth factor-beta 1 in hepatocellular carcinoma in comparison with the non-tumor tissue.
Idobe Y; Murawaki Y; Kitamura Y; Kawasaki H
Hepatogastroenterology; 2003; 50(49):54-9. PubMed ID: 12629989
[TBL] [Abstract][Full Text] [Related]
30. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer.
Kataoka A; Yuasa T; Kageyama S; Iwaki H; Higuchi K; Tanaka T; Okada Y; Yoshiki T
Oncol Rep; 2005 Apr; 13(4):597-600. PubMed ID: 15756429
[TBL] [Abstract][Full Text] [Related]
31. Neoangiogenesis in patients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphorylase.
Tsujitani S; Saito H; Maeta Y; Yamaguchi K; Tatebe S; Kondo A; Kaibara N
Anticancer Res; 2004; 24(3b):1853-9. PubMed ID: 15274366
[TBL] [Abstract][Full Text] [Related]
32. The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast.
Ellis PE; Wong Te Fong LF; Rolfe KJ; Crow JC; Reid WM; Davidson T; MacLean AB; Perret CW
Anticancer Res; 2002; 22(2A):857-61. PubMed ID: 12014662
[TBL] [Abstract][Full Text] [Related]
33. Comparison of ELISA level and immunohistochemical status for thymidine phosphorylase (TP) in invasive breast carcinoma.
Kurosumi M; Sugamata N; Tabei T; Inoue K; Matsumoto H; Suemasu K; Higashi Y
Anticancer Res; 2002; 22(1A):331-8. PubMed ID: 12017313
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma.
Choi YD; Cho NH; Ahn HS; Cho KS; Cho SY; Yang WJ
J Urol; 2007 Mar; 177(3):1174-8. PubMed ID: 17296440
[TBL] [Abstract][Full Text] [Related]
35. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human bladder cancer.
Tanaka T; Yoshiki T; Arai Y; Higuchi K; Kageyama S; Ogawa Y; Isono T; Okada Y
Jpn J Cancer Res; 1999 Dec; 90(12):1344-50. PubMed ID: 10665652
[TBL] [Abstract][Full Text] [Related]
36. Bladder microvasculature in women with interstitial cystitis.
Rosamilia A; Cann L; Dwyer P; Scurry J; Rogers P
J Urol; 1999 Jun; 161(6):1865-70. PubMed ID: 10332455
[TBL] [Abstract][Full Text] [Related]
37. Effect of comestibles on symptoms of interstitial cystitis.
Shorter B; Lesser M; Moldwin RM; Kushner L
J Urol; 2007 Jul; 178(1):145-52. PubMed ID: 17499305
[TBL] [Abstract][Full Text] [Related]
38. Defective Tamm-Horsfall protein in patients with interstitial cystitis.
Parsons CL; Stein P; Zupkas P; Chenoweth M; Argade SP; Proctor JG; Datta A; Trotter RN
J Urol; 2007 Dec; 178(6):2665-70. PubMed ID: 17945284
[TBL] [Abstract][Full Text] [Related]
39. Increased urinary hyaluronic acid and interstitial cystitis.
Erickson DR; Sheykhnazari M; Ordille S; Bhavanandan VP
J Urol; 1998 Oct; 160(4):1282-4. PubMed ID: 9751336
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Nov; 35(10):606-12. PubMed ID: 17032393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
